700 / 1084
Adjuvant chemotherapy was associated with a
statistically significant benefit in terms of overall
survival
(hazard ratio [HR], 0.82; 95% confidence interval
[CI], 0.76-0.90;
P
.001)
The estimated
median OS was 4.9 years
(95% CI, 4.4-
5.5)
in the surgery-only group
vs
7.8 years
(95% CI,
6.5-8.7) in the group receiving
adjuvant chemotherapy
Absolute benefits
were
5.8% at 5 years
(from 49.6%
to 55.3%) and
7.4% at 10 years
(from 37.5% to 44.9%)
03/27/2017